drugset / Trial / NCT00190944

Effects of Teriparatide on Distal Radius Fracture Healing

NCT00190944

Phase 2 Completed 105 enrolled Eli Lilly and Company
RandomizedParallel-groupDouble-blindTreatment

Summary

Effects of Teriparatide on Distal Radius Fracture Healing

Timeline

Start
2004-12
Primary completion
Completion
2007-06

Drugs

EvaluationDrugModalityDoseRoute
Subject Teriparatide Protein / enzyme biologic 20 ug
Subject Teriparatide Protein / enzyme biologic 40 ug

Indications

No indication recorded.